Literature DB >> 15138439

Methamphetamine activates reward circuitry in drug naïve human subjects.

Birgit A Völlm1, Ivan E de Araujo, Philip J Cowen, Edmund T Rolls, Morten L Kringelbach, Katharine A Smith, Peter Jezzard, Ronald J Heal, Paul M Matthews.   

Abstract

Amphetamines are highly addictive drugs that have pronounced effects on emotional and cognitive behavior in humans. These effects are mediated through their potent dopaminergic agonistic properties. Dopamine has also been implicated in the modulation of responses of the 'reward circuit' in animal and human studies. In this study we use functional magnetic resonance imaging (fMRI) to identify the brain circuitry involved in the psychostimulant effect of methamphetamine in psychostimulant-naïve human subjects. Seven healthy volunteers were scanned in a 3T MR imaging system. They received single-blind intravenous infusions of methamphetamine (0.15 mg/kg), and rated their experience of 'mind-racing' on a button press throughout the experiment. Data were analyzed with statistical parametric mapping methods. Amphetamine administration activated the medial orbitofrontal cortex, the rostral part of the anterior cingulate cortex, and the ventral striatum. Ratings of 'mind-racing' after methamphetamine infusion correlated with activations in the rostral part of the anterior cingulate cortex and in the ventral striatum. In addition, activations in the medial orbitofrontal cortex were independent of motor and related responses involved in making the ratings. These findings indicate that the first administration of a psychostimulant to human subjects activates classical reward circuitry. Our data also support recent hypotheses suggesting a central role for the orbitofrontal cortex in drug reinforcement and the development of addiction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138439     DOI: 10.1038/sj.npp.1300481

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  47 in total

1.  3-D cytoarchitectonic parcellation of human orbitofrontal cortex correlation with postmortem MRI.

Authors:  Harry B M Uylings; Ernesto J Sanz-Arigita; Koos de Vos; Chris W Pool; Paul Evers; Grazyna Rajkowska
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

2.  The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.

Authors:  Joshua S Beckmann; Emily D Denehy; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

Review 3.  The neural circuitry of reward and its relevance to psychiatric disorders.

Authors:  David T Chau; Robert M Roth; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

Review 4.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 5.  [Functional magnetic resonance imaging and antipsychotics. Overview and own data].

Authors:  D F Braus; S Brassen
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

6.  Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli.

Authors:  Thorsten Kienast; Thomas Siessmeier; Jana Wrase; Dieter F Braus; Michael N Smolka; Hans Georg Buchholz; Michael Rapp; Mathias Schreckenberger; Frank Rösch; Paul Cumming; Gerhard Gruender; Karl Mann; Peter Bartenstein; Andreas Heinz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-17       Impact factor: 9.236

7.  Dissociation of neural regions associated with anticipatory versus consummatory phases of incentive processing.

Authors:  Daniel G Dillon; Avram J Holmes; Allison L Jahn; Ryan Bogdan; Lawrence L Wald; Diego A Pizzagalli
Journal:  Psychophysiology       Date:  2007-09-10       Impact factor: 4.016

Review 8.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

9.  Carbohydrate sensing in the human mouth: effects on exercise performance and brain activity.

Authors:  E S Chambers; M W Bridge; D A Jones
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

10.  Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving.

Authors:  Hannah M Cates; Xuan Li; Immanuel Purushothaman; Pamela J Kennedy; Li Shen; Yavin Shaham; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.